+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Gastrointestinal Therapeutics Market Report by Type, Route of Administration, Application, Distribution Channel, and Region 2024-2032

  • PDF Icon

    Report

  • 144 Pages
  • August 2024
  • Region: Global
  • IMARC Group
  • ID: 5901537
Description Jump to:
The global gastrointestinal therapeutics market size reached US$ 46.5 Billion in 2023. Looking forward, the publisher expects the market to reach US$ 69.6 Billion by 2032, exhibiting a growth rate (CAGR) of 4.58% during 2023-2032.

Gastrointestinal (GI) syndrome refers to a medical ailment that affects the functioning of organs in the digestive tract. It impacts the stomach, pancreas, small and large intestines, gall bladder and liver and is usually characterized by indigestion, heartburn, constipation and bloating. Some of the commonly used GI therapeutics include prescription and over-the-counter (OTC) drugs, such as antacids, laxatives, antidiarrheal agents, antiemetics, antiulcer agents, and endoscopic and radiological procedures and hematological tests. These therapeutics assist in the detection of the disorder and absorbing nutrients from the food to improve digestion, regulate water flow in the GI system and minimize gastric acidity.

The increasing prevalence of GI diseases, such as inflammatory bowel disease (IBD) and ulcerative colitis, is one of the key factors driving the growth of the market. Due to changing lifestyle patterns and unhealthy dietary habits, there is an increased probability of disease recurrence among patients across the globe. Furthermore, the rising geriatric population, which is more susceptible to such ailments, is also driving the market growth. Various technological advancements, such as the development of innovative biosimilars and cellular therapies for the treatment of the disorder, are acting as other growth-inducing factors.

These biologics are administered through intravenous and subcutaneous injections and are personalized for targeted treatments. Other factors, including rising health consciousness among the masses, extensive research and development (R&D) activities and significant improvements in the healthcare infrastructure, especially in developing economies, are anticipated to drive the market further.

Key Market Segmentation:

The publisher provides an analysis of the key trends in each sub-segment of the global gastrointestinal therapeutics market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on type, route of administration, application and distribution channel.

Breakup by Type:

  • Branded
  • Generic

Breakup by Route of Administration:

  • Oral
  • Intravenous
  • Others

Breakup by Application:

  • Ulcerative Colitis
  • Crohn's Disease
  • GERD
  • Others

Breakup by Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, AbbVie Inc., AstraZeneca Plc, Bausch Health Companies Inc., Bayer Aktiengesellschaft, GlaxoSmithKline Plc, Janssen Biotech Inc. (Johnson & Johnson), Novo Nordisk A/S, Pfizer Inc., Sanofi S.A. and Takeda Pharmaceuticals.

Key Questions Answered in This Report:

  • How has the global gastrointestinal therapeutics market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global gastrointestinal therapeutics market?
  • What are the key regional markets?
  • What is the breakup of the market based on the type?
  • What is the breakup of the market based on the route of administration?
  • What is the breakup of the market based on the application?
  • What is the breakup of the market based on the distribution channel?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global gastrointestinal therapeutics market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Gastrointestinal Therapeutics Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Type
6.1 Branded
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Generic
6.2.1 Market Trends
6.2.2 Market Forecast
7 Market Breakup by Route of Administration
7.1 Oral
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Intravenous
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Others
7.3.1 Market Trends
7.3.2 Market Forecast
8 Market Breakup by Application
8.1 Ulcerative Colitis
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Crohn's Disease
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 GERD
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Others
8.4.1 Market Trends
8.4.2 Market Forecast
9 Market Breakup by Distribution Channel
9.1 Hospital Pharmacies
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Retail Pharmacies
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Online Pharmacies
9.3.1 Market Trends
9.3.2 Market Forecast
10 Market Breakup by Region
10.1 North America
10.1.1 United States
10.1.1.1 Market Trends
10.1.1.2 Market Forecast
10.1.2 Canada
10.1.2.1 Market Trends
10.1.2.2 Market Forecast
10.2 Asia-Pacific
10.2.1 China
10.2.1.1 Market Trends
10.2.1.2 Market Forecast
10.2.2 Japan
10.2.2.1 Market Trends
10.2.2.2 Market Forecast
10.2.3 India
10.2.3.1 Market Trends
10.2.3.2 Market Forecast
10.2.4 South Korea
10.2.4.1 Market Trends
10.2.4.2 Market Forecast
10.2.5 Australia
10.2.5.1 Market Trends
10.2.5.2 Market Forecast
10.2.6 Indonesia
10.2.6.1 Market Trends
10.2.6.2 Market Forecast
10.2.7 Others
10.2.7.1 Market Trends
10.2.7.2 Market Forecast
10.3 Europe
10.3.1 Germany
10.3.1.1 Market Trends
10.3.1.2 Market Forecast
10.3.2 France
10.3.2.1 Market Trends
10.3.2.2 Market Forecast
10.3.3 United Kingdom
10.3.3.1 Market Trends
10.3.3.2 Market Forecast
10.3.4 Italy
10.3.4.1 Market Trends
10.3.4.2 Market Forecast
10.3.5 Spain
10.3.5.1 Market Trends
10.3.5.2 Market Forecast
10.3.6 Russia
10.3.6.1 Market Trends
10.3.6.2 Market Forecast
10.3.7 Others
10.3.7.1 Market Trends
10.3.7.2 Market Forecast
10.4 Latin America
10.4.1 Brazil
10.4.1.1 Market Trends
10.4.1.2 Market Forecast
10.4.2 Mexico
10.4.2.1 Market Trends
10.4.2.2 Market Forecast
10.4.3 Others
10.4.3.1 Market Trends
10.4.3.2 Market Forecast
10.5 Middle East and Africa
10.5.1 Market Trends
10.5.2 Market Breakup by Country
10.5.3 Market Forecast
11 SWOT Analysis
11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats
12 Value Chain Analysis
13 Porters Five Forces Analysis
13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes
14 Price Analysis
15 Competitive Landscape
15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
15.3.1 Abbott Laboratories
15.3.1.1 Company Overview
15.3.1.2 Product Portfolio
15.3.1.3 Financials
15.3.1.4 SWOT Analysis
15.3.2 AbbVie Inc.
15.3.2.1 Company Overview
15.3.2.2 Product Portfolio
15.3.2.3 Financials
15.3.2.4 SWOT Analysis
15.3.3 AstraZeneca Plc
15.3.3.1 Company Overview
15.3.3.2 Product Portfolio
15.3.3.3 Financials
15.3.3.4 SWOT Analysis
15.3.4 Bausch Health Companies Inc.
15.3.4.1 Company Overview
15.3.4.2 Product Portfolio
15.3.4.3 Financials
15.3.4.4 SWOT Analysis
15.3.5 Bayer Aktiengesellschaft
15.3.5.1 Company Overview
15.3.5.2 Product Portfolio
15.3.5.3 Financials
15.3.5.4 SWOT Analysis
15.3.6 GlaxoSmithKline Plc
15.3.6.1 Company Overview
15.3.6.2 Product Portfolio
15.3.6.3 Financials
15.3.6.4 SWOT Analysis
15.3.7 Janssen Biotech Inc. (Johnson & Johnson)
15.3.7.1 Company Overview
15.3.7.2 Product Portfolio
15.3.8 Novo Nordisk A/S
15.3.8.1 Company Overview
15.3.8.2 Product Portfolio
15.3.8.3 Financials
15.3.8.4 SWOT Analysis
15.3.9 Pfizer Inc.
15.3.9.1 Company Overview
15.3.9.2 Product Portfolio
15.3.9.3 Financials
15.3.9.4 SWOT Analysis
15.3.10 Sanofi S.A.
15.3.10.1 Company Overview
15.3.10.2 Product Portfolio
15.3.10.3 Financials
15.3.10.4 SWOT Analysis
15.3.11 Takeda Pharmaceuticals
15.3.11.1 Company Overview
15.3.11.2 Product Portfolio
15.3.11.3 Financials
15.3.11.4 SWOT Analysis
List of Figures
Figure 1: Global: Gastrointestinal Therapeutics Market: Major Drivers and Challenges
Figure 2: Global: Gastrointestinal Therapeutics Market: Sales Value (in Billion US$), 2018-2023
Figure 3: Global: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Billion US$), 2024-2032
Figure 4: Global: Gastrointestinal Therapeutics Market: Breakup by Type (in %), 2023
Figure 5: Global: Gastrointestinal Therapeutics Market: Breakup by Route of Administration (in %), 2023
Figure 6: Global: Gastrointestinal Therapeutics Market: Breakup by Application (in %), 2023
Figure 7: Global: Gastrointestinal Therapeutics Market: Breakup by Distribution Channel (in %), 2023
Figure 8: Global: Gastrointestinal Therapeutics Market: Breakup by Region (in %), 2023
Figure 9: Global: Gastrointestinal Therapeutics (Branded) Market: Sales Value (in Million US$), 2018 & 2023
Figure 10: Global: Gastrointestinal Therapeutics (Branded) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 11: Global: Gastrointestinal Therapeutics (Generic) Market: Sales Value (in Million US$), 2018 & 2023
Figure 12: Global: Gastrointestinal Therapeutics (Generic) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 13: Global: Gastrointestinal Therapeutics (Oral) Market: Sales Value (in Million US$), 2018 & 2023
Figure 14: Global: Gastrointestinal Therapeutics (Oral) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 15: Global: Gastrointestinal Therapeutics (Intravenous) Market: Sales Value (in Million US$), 2018 & 2023
Figure 16: Global: Gastrointestinal Therapeutics (Intravenous) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 17: Global: Gastrointestinal Therapeutics (Others) Market: Sales Value (in Million US$), 2018 & 2023
Figure 18: Global: Gastrointestinal Therapeutics (Others) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 19: Global: Gastrointestinal Therapeutics (Ulcerative Colitis) Market: Sales Value (in Million US$), 2018 & 2023
Figure 20: Global: Gastrointestinal Therapeutics (Ulcerative Colitis) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 21: Global: Gastrointestinal Therapeutics (Crohn's Disease) Market: Sales Value (in Million US$), 2018 & 2023
Figure 22: Global: Gastrointestinal Therapeutics (Crohn's Disease) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 23: Global: Gastrointestinal Therapeutics (GERD) Market: Sales Value (in Million US$), 2018 & 2023
Figure 24: Global: Gastrointestinal Therapeutics (GERD) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 25: Global: Gastrointestinal Therapeutics (Others) Market: Sales Value (in Million US$), 2018 & 2023
Figure 26: Global: Gastrointestinal Therapeutics (Others) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 27: Global: Gastrointestinal Therapeutics (Hospital Pharmacies) Market: Sales Value (in Million US$), 2018 & 2023
Figure 28: Global: Gastrointestinal Therapeutics (Hospital Pharmacies) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 29: Global: Gastrointestinal Therapeutics (Retail Pharmacies) Market: Sales Value (in Million US$), 2018 & 2023
Figure 30: Global: Gastrointestinal Therapeutics (Retail Pharmacies) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 31: Global: Gastrointestinal Therapeutics (Online Pharmacies) Market: Sales Value (in Million US$), 2018 & 2023
Figure 32: Global: Gastrointestinal Therapeutics (Online Pharmacies) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 33: North America: Gastrointestinal Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
Figure 34: United States: Gastrointestinal Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
Figure 35: United States: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 36: Canada: Gastrointestinal Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
Figure 37: Canada: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 38: North America: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 39: Asia-Pacific: Gastrointestinal Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
Figure 40: China: Gastrointestinal Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
Figure 41: China: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 42: Japan: Gastrointestinal Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
Figure 43: Japan: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 44: India: Gastrointestinal Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
Figure 45: India: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 46: South Korea: Gastrointestinal Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
Figure 47: South Korea: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 48: Australia: Gastrointestinal Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
Figure 49: Australia: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 50: Indonesia: Gastrointestinal Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
Figure 51: Indonesia: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 52: Others: Gastrointestinal Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
Figure 53: Others: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 54: Asia-Pacific: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 55: Europe: Gastrointestinal Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
Figure 56: Germany: Gastrointestinal Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
Figure 57: Germany: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 58: France: Gastrointestinal Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
Figure 59: France: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 60: United Kingdom: Gastrointestinal Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
Figure 61: United Kingdom: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 62: Italy: Gastrointestinal Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
Figure 63: Italy: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 64: Spain: Gastrointestinal Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
Figure 65: Spain: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 66: Russia: Gastrointestinal Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
Figure 67: Russia: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 68: Others: Gastrointestinal Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
Figure 69: Others: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 70: Europe: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 71: Latin America: Gastrointestinal Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
Figure 72: Brazil: Gastrointestinal Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
Figure 73: Brazil: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 74: Mexico: Gastrointestinal Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
Figure 75: Mexico: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 76: Others: Gastrointestinal Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
Figure 77: Others: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 78: Latin America: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 79: Middle East and Africa: Gastrointestinal Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
Figure 80: Middle East and Africa: Gastrointestinal Therapeutics Market: Breakup by Country (in %), 2023
Figure 81: Middle East and Africa: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 82: Global: Gastrointestinal Therapeutics Industry: SWOT Analysis
Figure 83: Global: Gastrointestinal Therapeutics Industry: Value Chain Analysis
Figure 84: Global: Gastrointestinal Therapeutics Industry: Porter’s Five Forces Analysis
List of Tables
Table 1: Global: Gastrointestinal Therapeutics Market: Key Industry Highlights, 2023 and 2032
Table 2: Global: Gastrointestinal Therapeutics Market Forecast: Breakup by Type (in Million US$), 2024-2032
Table 3: Global: Gastrointestinal Therapeutics Market Forecast: Breakup by Route of Administration (in Million US$), 2024-2032
Table 4: Global: Gastrointestinal Therapeutics Market Forecast: Breakup by Application (in Million US$), 2024-2032
Table 5: Global: Gastrointestinal Therapeutics Market Forecast: Breakup by Distribution Channel (in Million US$), 2024-2032
Table 6: Global: Gastrointestinal Therapeutics Market Forecast: Breakup by Region (in Million US$), 2024-2032
Table 7: Global: Gastrointestinal Therapeutics Market: Competitive Structure
Table 8: Global: Gastrointestinal Therapeutics Market: Key Players

Companies Mentioned

  • Abbott Laboratories
  • AbbVie Inc.
  • AstraZeneca Plc
  • Bausch Health Companies Inc.
  • Bayer Aktiengesellschaft
  • GlaxoSmithKline Plc
  • Janssen Biotech Inc. (Johnson & Johnson)
  • Novo Nordisk A/S
  • Pfizer Inc.
  • Sanofi S.A.
  • Takeda Pharmaceuticals

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages144
PublishedAugust 2024
Forecast Period2023 - 2032
Estimated Market Value ( USD ) in 2023 $ 46.5 Billion
Forecasted Market Value ( USD ) by 2032 $ 69.6 Billion
Compound Annual Growth Rate4.6%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Gastrointestinal Drugs Market by Drug Category, Disease Type, Route of Administration, End User - Global Forecast 2025-2030 - Product Image

Gastrointestinal Drugs Market by Drug Category, Disease Type, Route of Administration, End User - Global Forecast 2025-2030

  • Report
  • 193 Pages
  • Global
From
Gastrointestinal Therapeutics - Global Strategic Business Report - Product Image

Gastrointestinal Therapeutics - Global Strategic Business Report

  • Report
  • 193 Pages
  • Global
From
Gastrointestinal OTC Drugs Market by Drug Class, Indication, End User, and Region 2024-2032 - Product Image

Gastrointestinal OTC Drugs Market by Drug Class, Indication, End User, and Region 2024-2032

  • Report
  • 145 Pages
  • Global
From
Gastrointestinal Diseases Therapeutics Market by Distribution Channel, Route of Administration, Application - Global Forecast 2025-2030 - Product Image

Gastrointestinal Diseases Therapeutics Market by Distribution Channel, Route of Administration, Application - Global Forecast 2025-2030

  • Report
  • 187 Pages
  • Global
From
Postoperative Gastrointestinal Dysfunction - Market Insight, Epidemiology and Market Forecast - 2034 - Product Image

Postoperative Gastrointestinal Dysfunction - Market Insight, Epidemiology and Market Forecast - 2034

  • Report
  • 200 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.